Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections (Q37913363)

25 August 2017

1 reference

title

Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections (English)

1 reference

25 August 2017

Stephan Ludwig

1

0 references

publication date

1 October 2011

1 reference

25 August 2017

1 reference

25 August 2017

392

1 reference

25 August 2017

837-847

1 reference

25 August 2017

10

1 reference

Novel influenza virus NS1 antagonists block replication and restore innate immune function

25 August 2017

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Multimeric glycotherapeutics: new paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Hsp90 inhibitors reduce influenza virus replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

JNK2 and IKKbeta are required for activating the innate response to viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Protein kinases--the major drug targets of the twenty-first century?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza A virus PB1-F2: a small protein with a big punch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

CYSTUS052, a polyphenol-rich plant extract, exerts anti-influenza virus activity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

A polyphenol rich plant extract, CYSTUS052, exerts anti influenza virus activity in cell culture without toxic side effects or the tendency to induce viral resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

A new player in a deadly game: influenza viruses and the PI3K/Akt signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Clustering of raft-associated proteins in the external membrane leaflet modulates internal leaflet H-ras diffusion and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Caspases disrupt the nuclear-cytoplasmic barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

In vitro and in vivo activities of anti-influenza virus compound T-705.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Peptide-mediated interference with influenza A virus polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza virus neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The multifunctional NS1 protein of influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Drosophila RNAi screen identifies host genes important for influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Natural polyphenols (vegetable tannins) as drugs: possible modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Developing new antiviral agents for influenza treatment: what does the future hold?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Sialidase-based anti-influenza virus therapy protects against secondary pneumococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL Src homology 3 domains to activate host cell signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

CRK adaptor protein expression is required for efficient replication of avian influenza A viruses and controls JNK-mediated apoptotic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Linear ubiquitin assembly complex negatively regulates RIG-I- and TRIM25-mediated type I interferon induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Effect of CYSTUS052 and green tea on subjective symptoms in patients with infection of the upper respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Human host factors required for influenza virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Apoptosis leads to a degradation of vital components of active nuclear transport and a dissociation of the nuclear lamina

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Suppressors of cytokine signaling and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

NF-kappaB signaling differentially regulates influenza virus RNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The potential impact of neuraminidase inhibitor resistant influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The use of an herbal formula by hospital care workers during the severe acute respiratory syndrome epidemic in Hong Kong to prevent severe acute respiratory syndrome transmission, relieve influenza-related symptoms, and improve quality of life: a pr

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza viruses and the NF-kappaB signaling pathway - towards a novel concept of antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza-virus-induced signaling cascades: targets for antiviral therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

MEK inhibition impairs influenza B virus propagation without emergence of resistant variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Disruption of the viral polymerase complex assembly as a novel approach to attenuate influenza A virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Membrane accumulation of influenza A virus hemagglutinin triggers nuclear export of the viral genome via protein kinase Calpha-mediated activation of ERK signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Development of an HTS assay for the search of anti-influenza agents targeting the interaction of viral RNA with the NS1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Antioxidant and prooxidant properties of a polyphenol-rich extract from Geranium sanguineum L. in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Inhibition of the infectivity of influenza virus by tea polyphenols

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The effectiveness of vaccination against influenza in healthy, working adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Active NF-kappaB signalling is a prerequisite for influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Preclinical in vitro activity of QR-435 against influenza A virus as a virucide and in paper masks for prevention of viral transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Activators and target genes of Rel/NF-kappaB transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Inhibition of influenza A virus replication by resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza A virus inhibits type I IFN signaling via NF-kappaB-dependent induction of SOCS-3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The M2 proton channels of influenza A and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Controlling influenza virus replication by inhibiting its proton channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

MEK-specific inhibitor U0126 blocks spread of Borna disease virus in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Essential impact of NF-kappaB signaling on the H5N1 influenza A virus-induced transcriptome

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Antiviral effect of catechins in green tea on influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Antibacterial Spectrum of Plant Polyphenols and Extracts Depending upon Hydroxyphenyl Structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Systematic review of influenza resistance to the neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

21 January 2018

Caspases: enemies within

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Identification of a PA-binding peptide with inhibitory activity against influenza A and B virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

NF-kappaB-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and Fas/FasL is crucial for efficient influenza virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Caspase 3 activation is essential for efficient influenza virus propagation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Exploited defense: how influenza viruses take advantage of antiviral signaling responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

Influenza viruses and MAP kinase cascades – Novel targets for an antiviral intervention?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2011.121

21 January 2018

Identifiers

DOI

10.1515/BC.2011.121

1 reference

25 August 2017

1 reference

PubMed ID

21823902